Patents for A61P 23 - Anaesthetics (4,141)
10/2001
10/04/2001WO2001019361A3 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
10/04/2001EP1138330A1 Combination of trimebutine with an opioid analgesic
09/2001
09/27/2001WO2001070744A2 Process for the preparation of midazolam
09/27/2001WO2001070577A1 Methods of producing a terminally sterilized topical patch preparation
09/27/2001WO2001070234A1 Anaesthetic composition
09/27/2001CA2402655A1 Process for the preparation of midazolam
09/25/2001US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/25/2001US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/20/2001WO2001068612A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
09/19/2001EP1133486A2 Nonsteroidal antiinflammatories
09/19/2001EP1133280A1 Method of preparing stable suspensions of insoluble microparticles
09/19/2001EP0871420B1 Triacetin as a transdermal penetration enhancer
09/19/2001CN1313758A Injectable aqueous dispersions of propofol
09/19/2001CN1313756A Oral liquid mucoadhesive compositions
09/19/2001CN1313754A Oral liquid mucoadhesive compositions
09/13/2001WO2001066091A1 Method of preparing solid dispersions
09/12/2001EP1131062A1 Injectable propofol formulations
09/11/2001US6288278 Benzene derived amino alcohols as drugs
09/11/2001US6288127 Adding lewis acid inhibitor
09/07/2001WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
09/07/2001WO2001064187A2 Anaesthetic formulations
09/07/2001CA2400138A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
09/06/2001US20010020024 Opioid analgesics
09/05/2001CN1311770A Derivatives of alpha-amino acid phenyl ester
09/04/2001US6284805 Aqueous solution of an acid addition salt of a 1-alkyl-n-(2,6-dimethylphenyl)-2-piperidinecaboxamide, wherein the solution is buffered.
09/04/2001US6284797 Capsaicin; norepinephrine inhibitor and a vasodilator which act to promote blood circulation in the treatment area
08/2001
08/30/2001WO2001062312A1 Foam-forming wound dressing
08/30/2001US20010018068 Water insoluble substrate comprising creped nonwoven layer and cleansing component (lathering surfactant); cleaning/ conditioning skin/hair; disposable; materials handling
08/30/2001CA2399211A1 Foam-forming wound dressing
08/29/2001EP1126848A1 Plastics container containing stabilised drug formulations
08/29/2001CN1310707A Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicaments
08/29/2001CN1070053C Method for preparing butethanol using for injection
08/28/2001US6281175 Medical emulsion for lubrication and delivery of drugs
08/28/2001CA2217888C Triacetin as a transdermal penetration enhancer
08/23/2001WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system
08/23/2001CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system
08/22/2001EP1124537A1 Propofol composition
08/22/2001EP1124536A1 Propofol composition comprising pentetate
08/22/2001CN1309562A Topical compositions comprising opioid analgesic and NMDA antagonist
08/22/2001CN1069826C Freezing-dried tetracaine hydrochloride powder injection
08/16/2001US20010014683 Analgesics; side effect reduction
08/16/2001EP1123072A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/15/2001CN1307900A Application of tigroid spider toxic extract in preparing analgesic
08/09/2001WO2001056576A1 Transdermal therapeutic system for the administration of zaleplon
08/09/2001DE10004790A1 Plaster-form transdermal therapeutic system containing zaleplon, especially for use as hypnotic agent, providing safe and controlled drug delivery
08/08/2001EP1122257A1 Benzimidazole compounds as ORL1-receptor agonists
08/08/2001EP1121109A2 Opioid analgesic
08/02/2001US20010011091 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/02/2001US20010011082 Mixture with chelate compound; bone disorders
08/01/2001EP0631503B1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
08/01/2001CN1305812A N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
08/01/2001CN1305791A Stretchable hood utensil contg. stretchable adhesive matrix at least in moisture state
07/2001
07/26/2001WO2001052859A1 Pharmaceutical parenteral composition containing a biphosphonate
07/26/2001US20010009921 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
07/25/2001EP1117399A1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
07/25/2001EP0741709B1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
07/24/2001US6264973 Apparatus and method for anesthetizing the cervical region of a female
07/19/2001WO2001050994A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof
07/19/2001US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
07/19/2001CA2366411A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof
07/17/2001US6262260 Process for the preparation of midazolam
07/12/2001WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
07/12/2001WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001DE19957287A1 Treatment of symptoms associated with loosening of implanted endoprostheses, e.g. pain, by administration of a homeopathic preparation of zinc or a zinc compound, e.g. zinc gluconate
07/12/2001DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives
07/12/2001DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives
07/12/2001CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives
07/12/2001CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/11/2001EP1114641A2 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
07/11/2001CN1303364A Aminocyclohexyl ether compounds and uses thereof
07/10/2001US6258374 Rectal or vaginal administration; polymer stabilizer; water soluble foam structure
07/05/2001WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
07/05/2001WO2001047559A1 Patches for external use
07/05/2001WO2001047508A2 Combination of trimebutine with an opioid analgesic
07/05/2001CA2394745A1 Combination of trimebutine with an opioid analgesic
07/04/2001CN1067989C New compound with analgesic and local anaesthetic effect
07/03/2001US6254887 Controlled release tramadol
07/03/2001CA2077641C Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief
06/2001
06/28/2001WO2001046263A1 Novel compounds
06/28/2001WO2001046174A1 Novel compounds
06/28/2001CA2395300A1 Novel compounds
06/28/2001CA2394864A1 Novel compounds
06/27/2001CN1301147A Pharmaceutical compositions capable of being gelled
06/26/2001US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics
06/26/2001CA2278133C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
06/21/2001WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
06/21/2001WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers
06/21/2001CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers
06/21/2001CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
06/20/2001EP1107738A1 Novel pharmaceutical salt form
06/20/2001EP1107733A1 Oral liquid mucoadhesive compositions
06/20/2001EP1107732A1 Oral liquid mucoadhesive compositions
06/19/2001US6248345 Prolonged anesthesia in joints and body spaces
06/14/2001WO2001008632A3 Colloidal composition for esthetic correction
06/13/2001EP1105098A1 Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
06/13/2001EP1105096A1 Injectable aqueous dispersions of propofol
06/13/2001EP0967975B1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
06/07/2001WO2001039723A2 Triazospiro compounds having nociceptin receptor affinity
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42